We are live on ! Find out more
ORIAW

Orion Biotech Opportunities Corp. Warrant
ORIAW

Delisted

ORIAW was delisted on the 28th of April, 2023.

30 hedge funds and large institutions have $2.63M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

15% more funds holding

Funds holding: 2630 (+4)

34% less capital invested

Capital invested by funds: $3.95M → $2.63M (-$1.33M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
6
Closed
2
Calls
$557K
Puts
Net Calls
+$557K
Net Calls Change
+$23K
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
Dupont Capital Management
Delaware
$7K
JG
27
Jefferies Group
New York
$6.79K
WA
28
Whitebox Advisors
Minnesota
$6K
CH
29
CVI Holdings
Delaware
$5K -$3.51K -6,810 -34%
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
-$28K -28,400 Closed
FLC
31
Fifth Lane Capital
Texas
-$4K -3,849 Closed
UBS Group
32
UBS Group
Switzerland
+$255 +495 New